Skip to content

Author

D. Krementsov

We have 3 of 89 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Integrated multi-omics analysis identifies microbial and metabolic signatures and drivers of CNS autoimmunity

ABSTRACT Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), driven by genetic and environmental determinants. The gut microbiome of people with MS (pwMS) is distinct and influences disease through immunomodulatory metabolite production. Circulating metabolites are altered in pwMS, but...

T. Montgomery, Emily A. Nelson, Lauren A. Downs et al. · 0 citations
Open access Jul 2026

Integrated multi-omics analysis identifies microbial and metabolic signatures and drivers of CNS autoimmunity 2305382

Dietary response is modulated by gut microbiome composition and that integrated microbiomic-metabolomic analyses can predict drivers of disease worsening in MS, indicate that dietary response is modulated by gut microbiome composition.

T. Montgomery, Emily A. Nelson, Lauren A. Downs et al. · 0 citations
Open access Jul 2026

Identification of Integrin αvβ3 as a Receptor for the Novel Macrophage-Secreted Microprotein U9-ORF Encoded by U90926 2307000

U9-ORF is a novel ligand for integrin αvβ3, which is upregulated on endothelial cells during inflammation, and thus could mediate protective effects of U90926 in sepsis, and thus could mediate protective effects of U90926 in sepsis.

T. Hogan, D. Krementsov · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.